Consumer Discretionary SPDR bounces off its 50-day moving average
In the strong reversal on May 10, many stocks and ETFs reversed from losses to gains throughout the day. One ETF in particular that caught my attention was the Consumer Discretionary Select Sector SPDR (NYSE: XLY).
The XLY dipped down to its 50-day moving average during the trading day, but then rallied back sharply to close higher. Back in August the XLY bounced off of the 50-day moving average on two occasions before moving to a new all-time high in September.
The reversal allowed the daily stochastic readings to make a bullish crossover and create a possible bullish signal. The indicators weren’t in oversold territory, but they made a similar move back in March before halting a brief pullback. After dipping down to the $107.50 level on March 8, the ETF rallied almost 10% over the next month.
The Tickeron AI Trend Prediction tool generated a bullish signal for the XLY on May 9 and that signal showed a confidence level of 77%. The signal calls for a gain of at least 4% over the next month. Previous predictions on the XLY have been successful an impressive 94% of the time.
XLY in +0.36% Uptrend, rising for three consecutive days on October 15, 2025
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where XLY advanced for three days, in of 364 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 54 cases where XLY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
XLY moved above its 50-day moving average on October 17, 2025 date and that indicates a change from a downward trend to an upward trend.
XLY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The 10-day RSI Indicator for XLY moved out of overbought territory on September 18, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on September 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on XLY as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for XLY turned negative on September 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for XLY entered a downward trend on October 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Category ConsumerDiscretionary
Advertisement